Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership13,459 shares
Latest Disclosed Value $ 194,618
Stifel Financial Corp reports 13.49% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 13,459 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $194,617 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 11,859 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 13.49% during the quarter. The current value of the position is $195,021 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 13,459 1,600 13.49 195 15.48 0.0000
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 11,859 -51,269 -81.21 169 -66.20 0.0002
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 63,128 1,578 2.56 497 41.19 0.0005
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 61,550 27,811 82.43 353 28.00 0.0003
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 33,739 -54,513 -61.77 275 -66.91 0.0003
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 88,252 -330 -0.37 831 -12.16 0.0009
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 88,582 -21,615 -19.61 946 -13.45 0.0010
2024-08-13 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 110,197 -3,520 -3.10 1,093 -18.37 0.0012
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 113,717 9,432 9.04 1,340 -9.47 0.0015
2024-02-12 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 104,285 -1,845 -1.74 1,480 14.65 0.0019
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 106,130 1,098 1.05 1,291 -2.20 0.0018
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 105,032 6,476 6.57 1,319 20.79 0.0018
2023-05-12 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 98,556 -44 -0.04 1,093 -9.23 0.0016
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 98,600 13,779 16.24 1,204 35.78 0.0018
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 84,821 2,434 2.95 886 0.11 0.0015
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 82,387 -60 -0.07 885 13.32 0.0014
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 82,447 3,960 5.05 781 -13.89 0.0011
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 78,487 21,912 38.73 907 67.96 0.0012
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 56,575 285 0.51 540 -0.55 0.0008
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 56,290 -3,192 -5.37 543 -7.65 0.0008
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 59,482 59,482 588 0.0010
2019-11-19 2019-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 0 -59,088 -100.00 0 -100.00
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 59,088 59,088 736 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.